Editorial: <scp><i>MTTP</i></scp>, hepatic steatosis, and plasma lipids—still more questions than answers. Authors' reply-Reference-Cited by-同舟云学术

Editorial: MTTP, hepatic steatosis, and plasma lipids—still more questions than answers. Authors' reply

Published:2023-07-15 Issue:3 Volume:58 Page:370-371
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Hehl Leonida¹,Schneider Carolin Victoria¹²³^ORCID,Rader Daniel J.⁴

Affiliation:

1. Department of Medicine III, Gastroenterology, Metabolic Diseases and Intensive Care University Hospital RWTH Aachen Aachen Germany

2. Department of Genetics, Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

3. The Institute for Translational Medicine and Therapeutics, The Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

4. Department of Medicine, Division of Translational Medicine and Human Genetics, Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

Abstract

LINKED CONTENTThis article is linked to Schneider et al papers. To view these articles, visit https://doi.org/10.1111/apt.17566 and https://doi.org/10.1111/apt.17611

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17624

Reference10 articles.

1. A coding variant in the microsomal triglyceride transfer protein reduces both hepatic steatosis and plasma lipids

2. Editorial: MTTP, hepatic steatosis and plasma lipids – still more questions than answers

3. The genetics of NAFLD

4. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

5. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis